Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Study to Evaluate Topical 2% Povidone-Iodine Gel (VBP-245) in Subjects With Verruca Vulgaris

NCT04253912 is registered in ClinicalTrials.gov with Veloce BioPharma LLC as lead sponsor.

NCT NCT04253912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04253912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-Blind, Randomized, Parallel Group, Placebo-Controlled, Study to Evaluate Topical 2% Povidone-Iodine Gel (VBP-245) in Subjects With Verruca Vulgaris
Lead sponsor
Veloce BioPharma LLC
Phase
Phase 2
Overall status
Unknown status
Start date
February 12, 2020
Completion date
April 30, 2021
Enrollment
90 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

warts